Tokyo Metropolitan Ohtsuka Hospital
Toshima Ku, Tokyo, Japan
Government hospital in Toshima, Tokyo
2 Chome-8-1 Minamiotsuka, Toshima City, Tokyo 170-8476
About Tokyo Metropolitan Ohtsuka Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Bayer
2
Keio University
1
Clinical Trials at Tokyo Metropolitan Ohtsuka Hospital
During the past decade, Tokyo Metropolitan Ohtsuka Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Aflibercept for Retinopathy of Prematurity - Intravitreal Injection Versus Laser Therapy
2019-09-25
2021-02-12
Completed
113
Extension Study to Evaluate the Long-term Outcomes of Subjects in Study 20090
2020-03-18
2025-07-03
Active, not recruiting
96
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Tokyo Metropolitan Ohtsuka Hospital"
#1 collaborator was "Regeneron Pharmaceuticals" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Tokyo Metropolitan Ohtsuka Hospital
According to Clinical.Site data, the most researched conditions in "Tokyo Metropolitan Ohtsuka Hospital" are
"Retinopathy of Prematurity (ROP)" (2 trials) and "Type 2 Diabets Mellitus" (1 trials). Many other conditions were trialed in "Tokyo Metropolitan Ohtsuka Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Tokyo Metropolitan Ohtsuka Hospital
Most popular intervention types in "Tokyo Metropolitan Ohtsuka Hospital" are "Drug" (3 trials) and "Procedure" (2 trials). Other intervention types were less common.
The name of intervention was led by "Eylea (Aflibercept, BAY86-5321)" (2 trials), "Laser photocoagulation" (2 trials) and "nateglinide(drug) mitiglinide(drug)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Tokyo Metropolitan Ohtsuka Hospital
The vast majority of trials in "Tokyo Metropolitan Ohtsuka Hospital" are
3 trials for "All" genders.
Clinical Trials Status at Tokyo Metropolitan Ohtsuka Hospital
Currently, there are NaN active trials in "Tokyo Metropolitan Ohtsuka Hospital".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Tokyo Metropolitan Ohtsuka Hospital,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Tokyo Metropolitan Ohtsuka Hospital, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".